News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALTANA Pharma (AAA) Files A Suit Against Reference Prices At The Social Court


10/19/2005 5:12:22 PM

ALTANA AG (NYSE:AAA)(FWB:ALT) announced today that at the beginning of December, ALTANA Pharma has filed a suit at the Social Court in Berlin against the central association (Spitzenverbaende) of the German statutory health insurance companies with reference to their classification of Pantozol(R) (Pantoprazole) as part of a reference price group. ALTANA Pharma is of the opinion that the therapeutical improvements of Pantozol(R), e.g. less interactions with other drugs, has not been taken into account in the establishment of reference price groups for the class of proton pump inhibitors. The suit is directed against this wrong decision as well as the missing transparency of the proceedings of the Federal Committee. Furthermore, reference prices for innovative drugs contravene the objectives of patent protection.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES